Glaucoma Surgery Devices Market By End User (Eye Hospital & Ophthalmology Clinic, Ambulatory Surgical Centers (ASCS), and Outpatient Surgical Centers,Surgery Type (Conventional Glaucoma Surgeries and Minimally Invasive Glaucoma Surgeries), Product (Implants & Stents, Glaucoma Drainage Devices, and Glaucoma Laser Devices) - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits - Forecast 2024-2032

Industry : Healthcare | Pages : 161 Pages | Upcoming : Jun 2024


In 2020, the global glaucoma surgery devices market reached a valuation of $818.46 million, and it is anticipated to surge to $6,514.07 million by 2030, exhibiting a remarkable compound annual growth rate (CAGR) of 24.60% from 2023 to 2030. Glaucoma encompasses a group of conditions that affect the optic nerve, leading to vision loss, often associated with increased intraocular pressure (IOP). Glaucoma surgery employs specialized devices to lower eye pressure, thus preventing or mitigating damage to the optic nerve.

The COVID-19 pandemic has significantly impeded the growth of this industry, with demand for glaucoma surgery devices expected to remain subdued in the short term. Governments have imposed restrictions and prohibitions on medical procedures, particularly elective surgeries, further hampering the demand for ophthalmic equipment. Consequently, the outbreak of COVID-19 has cast a negative shadow over the glaucoma surgical device market.

The market's growth is fueled by the increasing prevalence of glaucoma and the growing global elderly population, which is more susceptible to eye diseases. Additionally, the surge in demand for minimally invasive glaucoma surgery (MIGS) procedures and advancements in glaucoma surgery device technology have further propelled market growth.

However, the market faces challenges, including reimbursement barriers related to MIGS devices and the risk of post-operative complications associated with glaucoma surgeries. A shortage of skilled professionals to perform glaucoma surgeries, coupled with a lack of awareness about eye care in low-income economies, also hampers market growth. On the flip side, initiatives and programs aimed at reducing the burden of glaucoma worldwide and the high growth potential in untapped emerging economies present opportunities for manufacturers to capitalize on.

What is the Impact of COVID-19 Pandemic on the Glaucoma Surgery Devices Market?

The global healthcare sector has been disrupted by the COVID-19 pandemic, leading to temporary closures of numerous sub-domains, including various healthcare services. In particular, the glaucoma surgery device sector has been negatively affected. Reduced patient visits to clinics due to the pandemic have resulted in fewer elective eye surgeries performed in hospitals and clinics.

The COVID-19 outbreak has significantly impacted the global economy and disrupted general hospital care for non-COVID-19 patients. As hospitals and clinics faced closures during lockdowns, demand for glaucoma surgery devices experienced a short-term decline. For instance, according to a study published in the British Journal of Surgery, based on 12 weeks of peak disruption to hospital services due to COVID-19, approximately 28.4 million elective surgeries worldwide were either canceled or postponed in 2020. Additionally, an international consortium study conducted in May 2020 reported that over 580,000 planned surgeries in India were canceled or delayed due to the pandemic. Consequently, the postponement of these non-emergency services led to reduced demand for glaucoma surgery devices.

Glaucoma Surgery Devices Market Segmentation 

The global glaucoma surgery devices market is categorized based on surgery type, product, end user, and region to provide an extensive assessment of the market. Regarding surgery type, it is divided into conventional glaucoma surgeries and minimally invasive glaucoma surgeries. In terms of products, it includes implants & stents, glaucoma drainage devices, and glaucoma laser devices. The end-user segment consists of eye hospitals & ophthalmology clinics, ambulatory surgical centers (ASCS), and outpatient surgical centers. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

Within the surgery type segment, conventional glaucoma surgeries held the dominant position in the global glaucoma surgery device market in 2020. This trend is expected to persist throughout the forecast period due to factors such as the increasing success rate in reducing intraocular pressure and the cost-effectiveness of conventional glaucoma surgery. Additionally, the adoption of conventional glaucoma surgery as the primary choice of treatment in underdeveloped economies due to its lower cost compared to MIGS contributes to its continued dominance.

By Surgery Type

In the product segment, implants & stents emerged as the leading category in the global glaucoma surgery devices market in 2020 and is projected to maintain this position in the coming years. This is attributed to the growing demand for implants & stents in glaucoma surgery, as they are used to reduce intraocular pressure and enhance the outflow of intraocular fluid.

By end user, the eye hospitals & ophthalmology clinic segment commanded the largest market share in 2020 and is expected to maintain its dominance throughout the forecast period. This is driven by the increased adoption of glaucoma surgical devices in eye hospitals & ophthalmology clinics, the availability of eye surgeons, and a heightened focus on and investment in eye care by these establishments.

By Product

Snapshot of the Asia-Pacific glaucoma surgery devices market 

Asia-Pacific presents lucrative opportunities for key players in the glaucoma surgery devices market, showcasing the fastest growth rate during the forecast period. This growth is attributed to improvements in healthcare infrastructure, rising disposable incomes, the strong presence of domestic companies, and the availability of glaucoma surgery devices, healthcare reforms, and technological advancements in the region's healthcare sector. Furthermore, leading manufacturers are expanding their footprint in emerging Asian-Pacific nations to capitalize on potential growth prospects in the glaucoma surgery devices market.

Key Market Players

The report profiles key market players, including AbbVie Inc. (Allergan), Alcon Inc., Glaukos Corporation, Johnson & Johnson (Abbott Medical Optics), iStar Medical SA, Lumibird Medical (Ellex Medical Lasers Ltd), Lumenis Ltd, New World Medical, Inc., Santen Pharmaceutical Co. Ltd, and Topcon Corporation.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global glaucoma surgery devices market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the glaucoma surgery devices market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2023 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of glaucoma surgery devices used across the globe.

Glaucoma Surgery Devices Market Report Highlights

By Surgery Type

  • Conventional Glaucoma Surgeries
  • Minimally Invasive Glaucoma Surgeries

By Product

  • Implants & Stents
  • Glaucoma Drainage Devices
  • Glaucoma Laser Devices

By End User

  • Eye Hospital & Ophthalmology Clinic
  • Ambulatory Surgical Centers (ASCS)
  • Outpatient Surgical Centers

By Region

  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Turkey, Saudi Arabia, South Africa, Rest of LAMEA)


Table and Figures


At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)